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ABSTRACT
Objectives: To determine optimum measurements for
abdominal obesity and to assess the prevalence and
determinants of metabolic syndrome in Qatar.
Design: National health survey.
Setting: Qatar National STEPwise Survey conducted
by the Supreme Council of Health during 2012.
Participants: 2496 Qatari citizens aged 18–64
representative of the general population.

Primary and secondary outcome measures:
Measure of obesity (body mass index, waist
circumference or waist-to-height ratio) that best
identified the presence of at least 2 other factors of
metabolic syndrome; cut-off values of waist
circumference; frequency of metabolic syndrome.
Results: Waist circumference ≥102 for men and
≥94 cm for women was the best predictor of the
presence of other determinants of metabolic syndrome
(raised blood pressure, fasting blood glucose,
triglycerides and reduced high-density lipoprotein
cholesterol). Using these values, we identified 28% of
Qataris with metabolic syndrome, which is
considerably lower than the estimate of 37% calculated
using the International Diabetes Federation (IDF)
criteria. Restricting the analysis to participants without
known elevated blood pressure, elevated blood sugar
or diabetes 16.5% would be classified as having
metabolic syndrome. In a multivariable logistic
regression analysis, the prevalence of metabolic
syndrome increased steadily with age (OR=3.40 (95%
CI 2.02 to 5.74), OR=5.66 (3.65 to 8.78), OR=10.2
(5.98 to 17.6) and OR=18.2 (7.01 to 47.5) for those in
the age group ‘30–39’, ‘40–49’, ‘50–59’, ‘60–64’ vs
‘18–29’; p<0.0001), decreased with increasing
educational attainment (OR=0.61 (0.39 to 0.96) for
those who attained ‘secondary school or more’
compared with ‘less than primary school’; p=0.03) and
exercise (OR=0.60 (0.42 to 0.86) for those exercising
≥3000 vs <600 MET-min/week; p=0.006) but was not
associated with smoking or diet.
Conclusions: Waist circumference was the best
measure of obesity to combine with other variables to
construct a country-specific definition of metabolic
syndrome in Qatar. Approximately 28% of adult Qatari
citizens satisfy the criteria for metabolic syndrome,

Strengths and limitations of this study
▪ This is the first study to establish optimal cut-off
values for waist circumference for Qataris, which
is a crucial criterion for a realistic estimation of
the prevalence of metabolic syndrome in this
population.
▪ The study is based on a WHO STEPS survey, a
well-established and tested method specifically
for chronic non-communicable diseases (NCD)
risk factor surveillance.
▪ As for any population survey, the assumption is
made that the sample of individuals interviewed
is representative of the whole population.
which increased significantly with age. Education and
physical activity were inversely associated with this
syndrome.

INTRODUCTION
Metabolic syndrome is a combination of individual risk factors that are associated with
several serious health conditions such as diabetes, cardiovascular disease or stroke. It is diagnosed by the presence of three or more of
ﬁve risk factors: abdominal obesity, raised
blood pressure (BP), raised fasting blood
glucose, raised triglycerides and reduced
high-density lipoprotein (HDL) cholesterol.
The prevalence of metabolic syndrome is
therefore highly dependent on the cut-off
points used for the deﬁnition of each single
component of metabolic syndrome, and particularly for the deﬁnition of abdominal
obesity. Abdominal obesity is normally measured by waist circumference and broad
ethnic-group suboptimal cut-off points have
been proposed.1 2 Until more speciﬁc data are
available for Middle East countries, the
International Diabetes Federation (IDF)
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recommended using European cut-off points for all Eastern
Mediterranean and Middle East (Arab) populations.1
The aims of this study were: ﬁrst, to conﬁrm results
from a previous study3 showing that waist circumference
was an appropriate measure of central obesity for the
identiﬁcation of metabolic syndrome among Qatari citizens; second, to assess optimal cut-off points for waist circumference in Qataris from data in a representative
National Health Survey; third, to use these cut-off points
to determine the prevalence and fourth, the determinants of metabolic syndrome among Qatari citizens.

MATERIALS AND METHODS
Survey instrument and sampling
Qatar had a total adult population of about 1.5 million
inhabitants in 2010 comprising 240 000 Qatari Nationals
(39% aged <15, 58% aged 15–64 and 3% aged 65 or
more).4
We obtained survey data from a random sample of
2496 adult Qatari citizens aged 18–64 that were collected
during the year 2012 by the trained Qatar Supreme
Council of Health staff based on the WHO’s established
method for estimating non-communicable diseases
prevalence and risk factors, as part of surveillance.
The same standardised questions and protocols have
been used in many WHO member countries for monitoring within-country trends and for making comparisons across countries. General details on the survey are
available at the WHO website,5 and country-speciﬁc
details are available in a report from the Supreme
Council of Health, Qatar.6 Brieﬂy, a two-stage sample
design was used, selecting primary sampling units
(PSUs) at the ﬁrst stage and a sample of households
within each selected PSU at the second stage. A total of
96 PSUs were selected from the Qatari frame of PSUs.
In the second stage, 30 households were selected from
each selected PSU by simple systematic sampling.
Interviewers visited each selected household and identiﬁed all survey-eligible individuals. A personal digital
assistant device was used to generate a random number
to select one individual, either male or female, from
within the household. Only these selected individuals
were administered the questionnaire at their household.
Since biomedical tests require 12 hours of fasting,
appointments were given based on the agreement
between the interviewers and the respondents and were
conducted at the household level on Saturdays. In total
2496 of the 2850 Qatari households selected were interviewed, corresponding to an overall response rate of
88%. An Arabic standardised version of the stepwise
data collection form (Questionnaire) was used in the
survey, gathering:
▸ Demographic and behavioural risk factors: age, sex,
years at school, tobacco and smokeless tobacco use,
types of physical activity, sedentary behaviour, fruit
and vegetable consumption, history of raised BP,
history of diabetes and oral health;
2

▸ Physical measurements: height and weight, waist circumference, hip circumference, BP;
▸ Blood samples for biochemical measurements: fasting
blood glucose, total cholesterol, HDL cholesterol,
LDL-cholesterol and triglycerides.
All the Qatar national STEPwise questionnaires were
tested for cultural applicability and sensitivity through
word and pilot testing of the questionnaires.
This research proposal had been previously reviewed
and approved by the Qatar Supreme Council of Health.
The Ofﬁce of Research Integrity at Weill Cornell
Medical College in Qatar reviewed the proposal for secondary research analysis of those data by the authors
and determined that such secondary analysis was
exempt from Qatari and American human subject protection regulations and therefore did not require review
by an institutional review board.
Definition of metabolic syndrome and physical activity
assessment
Metabolic syndrome was deﬁned according to the IDF
criteria.1 It combines several individual risk factors
including raised fasting blood glucose (≥100 mg/dL
or taking diabetes medication), raised BP (systolic
BP≥130 mm Hg or diastolic BP≥85 mm Hg, or taking anti-hypertensive medication), raised triglycerides
(≥150 mg/dL), reduced HDL cholesterol (<40 in men
or <50 mg/dL in women) and central obesity deﬁned as
waist circumference with ethnicity speciﬁc values (using
Qatar-speciﬁc cut-offs estimated from this study: waist circumference ≥102 in men or ≥94 cm in women or body
mass index (BMI)≥30 kg/m2). According to the IDF criteria,1 if BMI is >30 kg/m2, central obesity can be
assumed and waist circumference does not need to be
measured. If three or more of these risk factors are
present, then metabolic syndrome is present.1
We calculated the total physical activity using the
Global Physical Activity Questionnaire developed by the
WHO.7 This instrument collects information on physical
activity participation in three settings (activity at work,
travel to and from places, recreational activities) and sedentary behaviour. Participants were categorised into low,
moderate and high levels of activity based on the sum of
their total metabolic equivalent (MET)-minutes of activity computed for each setting (1 MET being deﬁned as
1 kcal/kg/hour and is equivalent to the energy cost of
sitting quietly).
Data analysis
Demographic and health characteristics of the Qatari
population were evaluated using data from a crosssectional WHO STEPwise survey conducted in 2012.
The STEPS tool was designed to cover three levels of
risk factor assessment: step 1—demographic and behavioural risk factors information, step 2—physical measurements in household settings and step 3—biochemical
measurements. The data were weighted using population weights to adjust for age and sex differences
Al-Thani MH, et al. BMJ Open 2016;6:e009514. doi:10.1136/bmjopen-2015-009514
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between the sample and the national population.
Percentages, means and corresponding 95% CIs were
then calculated using the weighted data. Comparison of
percentages across groups of participants was assessed
using the Rao-Scott χ2 test, which is a design-adjusted
version of the Pearson χ2 test.
We evaluated the prevalence of each single component of metabolic syndrome in men and women by different age groups. We used the receiver operator
characteristic (ROC) curve analysis to assess the performance of various measures of obesity (BMI, waist circumference, waist-to-height ratio) for the identiﬁcation
of those with at least two other components of metabolic
syndrome and calculated the area under the curve
(AUC) (or ‘c-statistic’) to assess the prediction ability of
each parameter. Optimal waist circumference cut-off
points that maximise total accuracy (sensitivity and speciﬁcity) were calculated by the intersection of the plots of
sensitivity and speciﬁcity separately for men and for
women and combined with other measurements to
assess the prevalence of metabolic syndrome in Qatar.
Finally, we searched for lifestyle factors associated with
metabolic syndrome using logistic regression, adjusting
models for potential confounders such as age, gender or
educational attainment level. When present, missing
data were treated as a separate category and represented
by dummy variables, allowing logistic regression models
to be ﬁtted on the whole population.
Data analysis was performed using the SURVEYFREQ,
SURVEYMEANS, SURVEYREG and SURVEYLOGISTIC

procedures of the SAS software (V.9.2, Cary, North
Carolina, USA). All tests were two-sided and p values
<0.05 considered statistically signiﬁcant.
RESULTS
The survey sample consisted of 1053 male and 1443
female Qataris. Table 1 contains sociodemographic
characteristics of participants according to gender.
Signiﬁcant gender-related differences were observed for
educational attainment, with signiﬁcantly more women
(14.6%) than men (5.4%) who had attained less than
primary school, for marital status with more women than
men being divorced or widowed (6.4% and 3.9%, respectively, for women and 2.2% and 0.2% for men) and for
occupation with the majority of men (64.7%) being government employees, while homemakers were the largest
group in women (38.8%) ( p<0.0001). The age distribution ( p=0.21) was similar in men and women.
Best obesity measure that predicts metabolic syndrome
We performed ROC curve analysis to determine which
obesity measure (BMI, waist circumference or
waist-to-height ratio) and the corresponding cut-off
points that best predict metabolic syndrome. For this
analysis, we plotted the sensitivity versus 1-speciﬁcity for
all possible values of the three obesity measures to
predict the presence of at least two of the four remaining factors of metabolic syndrome (raised BP, raised
fasting blood glucose, raised triglycerides or reduced

Table 1 Sociodemographic characteristics of participants according to gender
Demographic information
Age group (years)
18–29
30–39
40–49
50–59
60–64
Educational attainment
Secondary school or more
Primary/preparatory school
Less than primary school
Marital status
Never married
Currently married
Divorced
Widowed
Occupation
Government employee
Non-government employee
Student
Homemaker
Retired
Other

Total (n=2496), %

Men (n=1053), %

Women (n=1443), %

100

100

100

40.1
25.7
19.5
11.1
3.6

39.6
27.5
17.8
11.0
4.1

40.6
24.0
21.1
11.2
3.1

67.0
22.8
10.1

67.4
27.1
5.4

66.7
18.7
14.6

29.8
63.8
4.3
2.1

30.1
67.5
2.2
0.2

29.5
60.2
6.4
3.9

49.1
5.6
13.4
19.9
7.5
4.4

64.7
8.7
11.3
0.5
8.8
6.1

34.0
2.7
15.5
38.8
6.3
2.7

Rao-Scott
χ2 (p value)
0.21

<0.0001

<0.0001

<0.0001

Al-Thani MH, et al. BMJ Open 2016;6:e009514. doi:10.1136/bmjopen-2015-009514

3

Downloaded from http://bmjopen.bmj.com/ on December 5, 2016 - Published by group.bmj.com

Open Access
HDL cholesterol) (ﬁgure 1). Waist circumference and
waist-to-height ratio were better predictors of metabolic
syndrome than BMI in men and women, yielding
respective moderate AUC of 0.612, 0.620 and 0.579 in
men and 0.722, 0.728 and 0.685 in women. The classiﬁer performance of waist circumference is, however,
only poor in men and fair in women.
We therefore conﬁrmed that waist circumference (criteria used by the IDF), which has similar predictive
value of metabolic syndrome than waist-to-height ratio
and necessitates a single measurement with no calculation, is an appropriate measure of central obesity. The
waist circumference cut-off points that maximised total
accuracy (sensitivity and speciﬁcity) were 102 for men
and 94 cm for women, respectively. The corresponding
sensitivity and speciﬁcity for the detection of metabolic
syndrome were 57.8% and 58.4% in men and 65.7%
and 66.7% in women.
Waist circumference distribution
We assessed the waist circumference of Qatari men and
women and the proportion of those with measures
above cut-off points deﬁned by the IDF in the absence
of ethnic-speciﬁc values (≥94 for men and ≥80 cm for
women), Adult Treatment Panel III (ATP-III) (≥102 for
men and ≥88 cm for women) or obtained from the previous ROC curves analysis for Qatari citizens (≥102 for
men and ≥94 cm for women) (table 2). Average waist
circumference was 100 cm (95% CI 98 to 102) for men
and 90 cm (95% CI 88 to 92) for women. Average waist
circumference increased steadily with age in both sexes
to reach 106 cm (95% CI 101 to 112) and 103 cm (95%
CI 98 to 108), respectively, for men and women aged

60–64. Using the cut-off points proposed by the IDF
(≥94 for men and ≥80 cm for women, ie, the same as
those used for Europeans), 63.4% of men and 68.5% of
women would be at risk, with the proportion as high as
77.1% in men and 92.4% in women aged 60 or more.
Using the less-stringent ATP-III2 cut-off points (≥102 for
men and ≥88 cm for women), the proportion of men
and women with a waist circumference indicative of
central obesity will diminish to 45.4% and 51.3%,
respectively (for all age groups). Using Qatar-speciﬁc
cut-off points identiﬁed by ROC curve analysis (≥102 for
men and ≥94 cm for women), only 45.4% of men and
38.7% of women would be considered to have waist
measurement indicative of central obesity.
Prevalence of metabolic syndrome
The prevalence of metabolic syndrome and its components is presented in table 3, stratiﬁed by gender and
age group. This information was collected at different
steps of the survey and was available for a variable
number of participants (1470 for fasting blood glucose,
2342 for BP, 1518 for triglycerides level, 1526 for HDL
cholesterol and 2356 for abdominal obesity). As a result,
information on metabolic syndrome was available for
1373 (55%) participants.
Considering all age groups together, reduced HDL
cholesterol (51.9%) and abdominal obesity (50.7%)
were the most common single components of metabolic
syndrome in men, while abdominal obesity (50.5%) and
raised BP (43.3%) were the most common single components of metabolic syndrome in women.
Overall, the prevalence of metabolic syndrome in
Qatar based on country-speciﬁc estimates of waist

Figure 1 Receiver operator characteristic (ROC) curves for body mass index, waist circumference and waist-to-height ratio to
predict the presence of at least two factors of metabolic syndrome (excluding abdominal obesity) in men and women in Qatar.
Information on body mass index was available for 2384 participants, waist circumference for 2335 participants and waist-to-height
ratio for 2333 participants.
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(90 to 94)
(75.5% to 85.1%)
(51.5% to 63.6%)
(33.2% to 46.7%)

98 cm (95 to 100)
102 cm
90.0% (85.2% to 94.7%) 93.3%
70.2% (63.8% to 76.6%) 78.1%
54.3% (46.4% to 62.2%) 63.9%

(98 to 105)
103 cm
(87.7% to 98.8%) 92.4%
(70.3% to 85.9%) 85.9%
(55.0% to 72.9%) 77.2%

(98 to 108)
(83.8% to 100%)
(74.7% to 97.2%)
(62.3% to 92.0%)

circumference was 27.7% (95% CI 24.5% to 30.9%) for
both sexes combined, 28.7% (95% CI 23.6% to 33.7%)
in men and 26.8% (95% CI 23.1% to 30.4%) in women.
This prevalence increases with age from 9.3% (95% CI
6.0% to 12.7%) in those under the age of 30 to 70.2%
(95% CI 54.1% to 86.3%) in those aged 60–64.

Information on waist circumference was available for 2335 participants.
*International Diabetes Federation (IDF) values for Europeans.
†Adult Treatment Panel III (ATP)-III values for USA.
‡Qatar-specific values defined with receiver operator characteristic analysis.

92 cm
80.3%
57.5%
40.0%
(77 to 82)
(30.9% to 46.0%)
(18.1% to 31.2%)
(12.0% to 22.8%)
80 cm
38.5%
24.7%
17.4%

94 cm (92 to 97)
102 cm (100 to 105)
103 cm (101 to 105)
107 cm (104 to 111)
106 cm (101 to 112)
45.3% (38.2% to 52.3%) 69.7% (62.5% to 76.9%) 87.5% (72.2% to 84.7%) 84.6% (77.7% to 91.4%) 77.1% (60.1% to 94.2%)
35.0% (28.1% to 41.9%) 46.8% (37.7% to 55.9%) 51.7% (43.5% to 59.9%) 61.8% (52.6% to 71.1%) 67.4% (49.3% to 85.5%)

40–49 years
30–39 years
18–29 years
(95% CI)
All age groups
N

Men
Mean waist circumference
1021 100 cm (98 to 102)
Proportion with waist ≥94 cm*
686 63.4% (58.7% to 68.2%)
Proportion with waist ≥102 cm†,‡ 480 45.4% (40.1% to 50.8%)
Women
Mean waist circumference
1314 90 cm (88 to 92)
Proportion with waist ≥80 cm*
985 68.5% (64.3% to 72.7%)
Proportion with waist ≥88 cm†
775 51.3% (47.3% to 55.3%)
Proportion with waist ≥94 cm‡
607 38.7% (34.7% to 42.7%)

Table 2

Weighted prevalence of suboptimal waist circumference by sex and age group among Qataris using different cut-off points

50–59 years

60–64 years
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Determinants of metabolic syndrome
We used multivariable logistic regression to identify
sociodemographic or lifestyle factors associated with
metabolic syndrome (table 4). After adjustment for age
and educational attainment level, gender was not associated with the risk of metabolic syndrome. The risk of
metabolic syndrome, however, signiﬁcantly increased
with increasing age with OR=3.40 (95% CI 2.02 to 5.74);
OR=5.66 (95% CI 3.65 to 8.78); OR=10.2 (95% CI 5.98
to 17.6) and OR=18.2 (95% CI 7.01 to 47.5) for those in
the age group ‘30–39’, ‘40–49’, ‘50–59’, ‘60–64’ compared with those in the ‘18–29’ age group ( p<0.0001),
but decreased with increasing educational attainment
with OR=0.61 (95% CI 0.39 to 0.96) for those who
attained ‘secondary school or more’ compared with ‘less
than primary school’ ( p=0.03). No statistical signiﬁcant
association was observed for marital status or occupation.
The particularly low but not statistically signiﬁcant risk
for students may be in part due to residual confounding
from age, marital status and physical activity.
Neither tobacco smoking nor any single component
of the diet recorded at the survey (see online supplementary table) was associated with metabolic syndrome.
After adjustment for age, gender and educational attainment, the risk of metabolic syndrome was reduced by
40% for those with high physical activity levels (at least
3000 MET-min/week) compared with those with low
physical activity level (<600 MET-min/week) (OR=0.60;
95% CI 0.42 to 0.86) ( p=0.006).
Metabolic syndrome among ‘healthy’ individuals
The survey was conducted to be representative of the
general population and therefore included a proportion
of participants with previous diagnosis of diabetes or
hypertension. Overall, 70% of the participants with available information about metabolic syndrome had never
been previously told by a doctor or other health worker
that they had either hypertension or diabetes. We reassessed the prevalence of metabolic syndrome and its
components among these presumed ‘healthy participants’ (table 5). In this subset, the survey eventually
found that 13.7% (95% CI 10.1% to 17.2%) had elevated fasting blood glucose, and 31.6% (95% CI 28.8%
to 34.4%) had raised BP; metabolic syndrome was
present in 16.5% (95% CI 13.5% to 19.5%).
DISCUSSION
Health professionals depend on estimates of the frequency of metabolic syndrome to plan effective strategies for controlling several serious conditions within a
5
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6
Weighted prevalence of metabolic syndrome and its components by sex and age group among Qataris
% (95% CI)
N exposed/
N available All age groups
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Both sexes (n=2496)
Metabolic syndrome (≥3 risk factors)* 430/1373
Raised fasting blood glucose†
374/1470
Raised BP‡
1107/2432
Raised triglycerides§
270/1518
Reduced HDL cholesterol¶
676/1526
Abdominal obesity**
1302/2356
Men (n=1053)
Metabolic syndrome (≥3 risk factors)* 179/538
Raised fasting blood glucose†
152/552
Raised BP‡
470/1022
Raised triglycerides§
110/573
Reduced HDL cholesterol¶
290/575
Abdominal obesity**
541/1031
Women (n=1443)
Metabolic syndrome (≥3 risk factors)* 251/835
Raised fasting blood glucose†
222/918
Raised BP‡
637/1410
Raised triglycerides§
160/945
Reduced HDL cholesterol¶
386/951
Abdominal obesity**
761/1325

18–29 years

30–39 years

40–49 years

50–59 years

60–64 years

27.7%
22.5%
42.7%
16.4%
45.5%
50.6%

(24.5%
(19.0%
(40.0%
(13.7%
(41.3%
(47.7%

to
to
to
to
to
to

30.9%)
26.0%)
45.4%)
19.0%)
49.8%)
53.6%)

9.3%
12.3%
28.2%
9.0%
38.4%
33.0%

(6.0% to 12.7%)
(7.9% to 16.8%)
(23.7% to 32.6%)
(5.7% to 12.3%)
(31.7% to 45.1%)
(28.1% to 37.9%)

26.0%
15.7%
36.2%
18.1%
48.1%
54.2%

(19.8% to 32.3%)
(9.6% to 21.9%)
(31.6% to 40.9%)
(12.7% to 23.5%)
(40.8% to 55.3%)
(49.0% to 59.5%)

37.9%
31.0%
54.9%
20.6%
49.1%
64.4%

(32.2%
(24.7%
(50.2%
(15.9%
(42.4%
(59.7%

to
to
to
to
to
to

43.6%)
37.4%)
59.6%)
25.2%)
55.7%)
69.2%)

54.0%
44.7%
73.9%
26.5%
51.7%
68.9%

(45.2%
(35.8%
(68.0%
(18.0%
(43.7%
(62.7%

to
to
to
to
to
to

62.7%)
53.7%)
79.8%)
35.0%)
59.7%)
75.1%)

70.2%
55.0%
87.5%
24.2%
62.3%
75.6%

(54.1%
(40.3%
(78.4%
(12.7%
(47.6%
(64.0%

28.7%
23.1%
42.1%
17.2%
51.9%
50.7%

(23.6%
(17.6%
(38.5%
(13.0%
(45.2%
(46.0%

to
to
to
to
to
to

33.7%)
28.6%)
45.6%)
21.3%)
58.6%)
55.5%)

9.5%
11.4%
25.8%
6.5%
45.8%
38.6%

(4.4% to 14.6%)
(6.0% to 16.9%)
(20.0% to 31.7%)
(1.5% to 11.4%)
(34.9% to 56.7%)
(31.2% to 46.0%)

26.4%
13.6%
35.1%
21.2%
53.8%
54.9%

(17.8% to 34.9%)
(5.2% to 21.9%)
(28.3% to 41.9%)
(12.7% to 29.7%)
(41.1% to 66.5%)
(46.7% to 63.1%)

38.5%
34.6%
54.5%
20.4%
54.6%
58.7%

(30.2%
(24.3%
(47.5%
(13.6%
(45.8%
(50.9%

to
to
to
to
to
to

46.9%)
44.9%)
61.5%)
27.3%)
63.5%)
66.5%)

62.3%
50.8%
80.1%
33.3%
56.7%
64.2%

(50.0%
(36.7%
(73.2%
(19.2%
(45.9%
(55.1%

to
to
to
to
to
to

74.5%)
64.9%)
86.9%)
47.3%)
67.4%)
73.3%)

66.6%
55.5%
86.9%
25.4%
65.0%
68.1%

(42.0% to 91.2%)
(32.3% to 78.6%)
(74.8% to 99.0%)
(9.4% to 41.5%)
(43.6% to 86.3%)
(50.1% to 86.0%)

26.8%
21.9%
43.3%
15.6%
39.4%
50.5%

(23.1%
(17.7%
(38.9%
(12.6%
(34.6%
(47.1%

to
to
to
to
to
to

30.4%)
26.1%)
47.6%)
18.6%)
44.2%)
53.9%)

9.1%
13.1%
30.3%
11.2%
31.7%
26.9%

(4.2% to 14.0%)
(7.1% to 19.2%)
(23.5% to 37.2%)
(6.2% to 16.2%)
(24.4% to 39.0%)
(20.9% to 33.0%)

25.6%
18.2%
37.4%
14.6%
41.5%
53.5%

(17.7% to 33.5%)
(10.6% to 25.8%)
(30.3% to 44.4%)
(8.8% to 20.4%)
(33.4% to 49.6%)
(46.9% to 60.0%)

37.3%
27.9%
55.2%
20.7%
44.1%
69.2%

(28.6%
(20.3%
(48.3%
(14.8%
(35.3%
(63.6%

to
to
to
to
to
to

46.0%)
35.6%)
62.0%)
26.5%)
52.9%)
74.8%)

46.7%
39.5%
67.9%
20.8%
47.4%
73.6%

(37.2%
(26.9%
(60.5%
(13.2%
(36.9%
(65.5%

to
to
to
to
to
to

56.2%)
52.0%)
75.3%)
28.3%)
58.0%)
81.6%)

75.8%
54.2%
88.3%
22.3%
58.0%
85.1%

(59.0% to 92.6%)
(34.5% to 74.0%)
(79.3% to 97.4%)
(6.3% to 38.2%)
(37.7% to 78.3%)
(73.7% to 96.5%)

*Metabolic syndrome status could only be determined for 1373 participants (538 men, 835 women) having complete data for the five components.
†Raised fasting blood glucose (≥100 mg/dL or previously diagnosed type 2 diabetes).
‡Raised BP (systolic BP≥130 or diastolic BP≥85 mm Hg or treatment of previously diagnosed hypertension).
§Raised triglycerides (≥150 mg/dL or specific treatment for this lipid abnormality).
¶Reduced HDL cholesterol (<40 mg/dL in men; <50 mg/dL in women or specific treatment for this lipid abnormality).
**Abdominal obesity (waist ≥102 cm in men or ≥94 cm in women or BMI≥30 kg/m2).
BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein.

to 86.3%)
to 69.7%)
to 96.7%)
to 35.8%)
to 77.0%)
to 87.3%)
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Table 4 Characteristics associated with metabolic syndrome at multivariable analysis
Characteristics*

Total

Percentage of participants
with metabolic syndrome

All
Gender
Men
Women
Age group (years)
18–29
30–39
40–49
50–59
60–64
Education
Less than primary school
Primary/preparatory school
Secondary school or more
Marital status
Never married
Currently married
Divorced
Widowed
Occupation
Government employee
Non-government employee
Student
Homemaker
Retired
Tobacco smoking‡
Never smoked tobacco
Ever smoked tobacco
Currently smoke tobacco
Currently smoke daily tobacco
Physical activity
Low (<600 MET-min/week)
Average (600–3000 MET-min/week)
High (≥3000 MET-min/week)

1373

27.7

538
835

28.7
26.8

337
353
396
214
73

9.3
26.0
37.9
54.0
70.2

169
312
891

50.0
30.3
23.3

1.00
0.70 (0.39 to 1.26)
0.61 (0.39 to 0.96)

263
979
81
50

10.3
33.2
41.8
52.5

1.00
1.40 (0.67 to 2.94)
1.97 (0.87 to 4.43)
1.73 (0.51 to 5.90)

631
64
117
354
157

24.2
23.7
4.3
37.6
53.6

1.00
1.07
0.38
1.56
1.53

1126
247
195
177

28.1
26.5
23.7
23.4

1.00
0.76 (0.47 to 1.23)
0.72 (0.47 to 1.12)
0.71 (0.45 to 1.12)

643
304
398

31.9
29.3
20.4

1.00
0.90 (0.64 to 1.28)
0.60 (0.42 to 0.86)

OR (95% CI)†

1.00
0.83 (0.62 to 1.12)
1.00
3.40 (2.02 to
5.66 (3.65 to
10.25 (5.98 to
18.24 (7.01 to

5.74)
8.78)
17.6)
47.5)

(0.40 to 2.83)
(0.14 to 1.06)
(0.94 to 2.59)
(0.94 to 2.49)

Information on education was not available for 1 participant, occupation for 50 participants and physical activity for 28 participants.
*Results are not presented when based on responses from <30 participants.
†ORs and 95% CIs obtained from multivariable logistic regression model adjusted for age, sex and education level.
‡Any form of tobacco including cigarettes, cigars, pipe, Shisha or Medwakh.

given population. Thus, it is extremely important that
the estimated prevalence of metabolic syndrome be reliable and based on information that is appropriate for
the selected region or country.
The major organisations concerned with deﬁning
metabolic syndrome recognise that central adiposity—an
important component of this syndrome—is most easily
measured by waist circumference.1 2 Furthermore, the
IDF has emphasised the need for determining countryspeciﬁc estimates of cut-off points for waist circumference in calculating the prevalence of metabolic
syndrome. In fact, there is good evidence that body composition varies among ethnic groups, Asians having
lower cut-off points than Europeans, and AfricanAmericans and Hispanics having similar cut-off points to
Europeans. Differences between populations could relate
to genetic differences that may affect body composition,
Al-Thani MH, et al. BMJ Open 2016;6:e009514. doi:10.1136/bmjopen-2015-009514

environmental exposure and particularly nutritional differences such as early childhood nutrition exposures.8 A
number of region-speciﬁc or population-speciﬁc estimates
have been published, but there are only a few for Middle
East countries and none for Qatar (table 6).
In previous publications, Bener et al3 9 suggested that
previous criteria for estimating the risk of metabolic syndrome as recommended by the WHO, the IDF and
ATP-III might be inappropriate for Qatar. In particular,
he and his coauthors proposed BMI, waist-to-hip and
waist-to-height ratio in alternative to waist circumference
as a measure of central obesity.3 We used data from the
2012 Qatar National STEPwise Survey to calculate the
current prevalence of metabolic syndrome in Qatar. We
conﬁrmed that waist circumference was an appropriate
parameter for identifying other individual components
of metabolic syndrome. For the entire Qatari adult
7
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8
% (95% CI)

Al-Thani MH, et al. BMJ Open 2016;6:e009514. doi:10.1136/bmjopen-2015-009514

Both sexes (n=1785)
Metabolic syndrome (≥3 risk factors)*
Raised fasting blood glucose†
Raised BP‡
Raised triglycerides§
Reduced HDL cholesterol¶
Abdominal obesity**
Men (n=765)
Metabolic syndrome (≥3 risk factors)*
Raised fasting blood glucose†
Raised BP‡
Raised triglycerides§
Reduced HDL cholesterol¶
Abdominal obesity**
Women (n=1020)
Metabolic syndrome (≥3 risk factors)*
Raised fasting blood glucose†
Raised BP‡
Raised triglycerides§
Reduced HDL cholesterol¶
Abdominal obesity**

N exposed/
N available

All age groups

18–29 years

30–39 years

40–49 years

177/963
151/1042
568/1733
147/1077
441/1083
783/1666

16.5%
13.7%
31.6%
12.4%
42.9%
43.8%

(13.5% to 19.5%)
(10.1% to 17.2%)
(28.8% to 34.4%)
(9.9% to 14.8%)
(38.1% to 47.8%)
(40.2% to 47.4%)

5.5%
9.8%
24.0%
7.9%
38.3%
31.2%

(2.6% to 8.4%)
(5.4% to 14.3%)
(19.9% to 28.1%)
(4.6% to 11.2%)
(30.9% to 45.8%)
(25.8% to 36.6%)

22.0%
13.6%
31.5%
15.6%
46.5%
51.2%

(15.5% to 28.4%)
(7.3% to 19.8%)
(26.2% to 36.8%)
(10.5% to 20.7%)
(38.5% to 54.5%)
(44.8% to 57.6%)

25.9%
19.5%
45.0%
15.3%
47.9%
57.1%

(19.5%
(13.7%
(39.2%
(10.4%
(39.4%
(51.1%

to
to
to
to
to
to

32.3%)
25.3%)
50.8%)
20.3%)
56.4%)
63.1%)

31.3%
20.8%
48.2%
19.8%
40.5%
61.4%

(19.1% to 43.4%)
(11.6% to 30.0%)
(37.7% to 58.7%)
(8.3% to 31.3%)
(29.1% to 51.9%)
(52.2% to 70.6%)

81/390
59/399
243/741
62/415
195/416
351/750

17.6%
13.0%
30.3%
13.4%
49.3%
46.1%

(13.1% to 22.1%)
(7.9% to 18.1%)
(26.4% to 34.2%)
(9.2% to 17.7%)
(41.1% to 57.4%)
(40.6% to 51.6%)

5.0%
7.4%
21.4%
6.3%
44.7%
38.2%

(1.1% to 8.8%)
(2.9% to 11.8%)
(15.4% to 27.4%)
(1.0% to 11.6%)
(33.0% to 56.4%)
(30.4% to 46.0%)

24.1%
12.4%
30.7%
18.2%
52.6%
52.2%

(15.1% to 33.0%)
(3.7% to 21.1%)
(23.2% to 38.2%)
(9.7% to 26.7%)
(39.1% to 66.1%)
(43.3% to 61.2%)

28.3%
22.9%
44.5%
18.7%
53.0%
53.9%

(19.0%
(12.9%
(36.1%
(11.4%
(41.8%
(44.2%

to
to
to
to
to
to

37.6%)
32.9%)
52.9%)
26.0%)
64.2%)
63.7%)

34.3%
25.1%
51.5%
25.6%
47.8%
50.9%

(16.1% to 52.5%)
(9.3% to 40.9%)
(37.7% to 65.3%)
(5.5% to 45.7%)
(28.5% to 67.1%)
(36.4% to 65.3%)

96/573
92/643
325/992
85/662
246/667
432/916

15.3%
14.3%
32.9%
11.3%
36.4%
41.3%

(11.8% to 18.8%)
(10.0% to 18.6%)
(28.5% to 37.3%)
(8.2% to 14.3%)
(30.9% to 41.9%)
(37.6% to 45.1%)

6.0%
12.0%
26.5%
9.4%
32.5%
23.4%

(2.1% to 10.0%)
(5.5% to 18.5%)
(20.2% to 32.7%)
(4.7% to 14.1%)
(24.4% to 40.5%)
(17.1% to 29.7%)

19.0%
15.1%
32.4%
12.4%
38.9%
49.8%

(11.3% to 26.7%)
(8.1% to 22.0%)
(25.4% to 39.4%)
(7.4% to 17.4%)
(30.1% to 47.6%)
(43.0% to 56.6%)

23.5%
16.2%
45.4%
12.1%
43.0%
60.0%

(14.8% to 32.3%)
(9.6% to 22.8%)
(37.6% to 53.3%)
(6.6% to 17.7%)
(32.2% to 53.9%)
(52.6% to 67.3%)

29.2%
17.9%
45.8%
15.5%
35.0%
69.0%

(15.1% to 43.3%)
(5.9% to 29.9%)
(32.7% to 59.0%)
(4.2% to 26.8%)
(20.9% to 49.2%)
(56.2% to 82.0%)

Results for those aged 60–64 years are not presented because they are based on responses from <30 participants.
*Metabolic syndrome status could only be determined for 963 participants (390 men, 573 women) having complete data for the five components.
†Raised fasting blood glucose (≥100 mg/dL or previously diagnosed type 2 diabetes).
‡Raised BP (systolic BP≥130 or diastolic BP≥85 mm Hg or treatment of previously diagnosed hypertension).
§Raised triglycerides (≥150 mg/dL or specific treatment for this lipid abnormality).
¶Reduced HDL cholesterol (<40 mg/dL in men; <50 mg/dL in women or specific treatment for this lipid abnormality).
**Abdominal obesity (waist ≥102 cm in men or ≥94 cm in women or BMI≥30 kg/m2).
BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein.

50–59 years
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Table 6 Ethnic specific values for waist circumference
from selected Middle East countries
Ethnic specific
values for waist
circumference
(cm)
Region/
population

Men

Women Reference

Iran
Iran
Iran
Iran
Iran
Iran
Iran, Kerman
Iraq
Jordan
Omani Arabs
Omani Arabs
Egypt
Qatar

89
94.5
92.6
92
94.5
91.5
89
97
97.8
80
78.5
93.5
102

91
94.5
97.8
95
–
85.5
86
99
95.6
84.5
84.5
91.5
94

Delavari et al11
Hadaegh et al12
Talaei et al13
Mirmiran et al14
Gharipour et al15
Esteghamati et al16
Gozashti et al17
Mansour et al18
Al-Odat et al19
Al-Lawati et al20
Al-Lawati et al21
Ibrahim et al22
Current study

population, using the best cut-off points for waist circumference, we estimate the prevalence of metabolic
syndrome in adults to be 28%. This value resembles the
previous overall estimate of 26% for this country
obtained using the ATP-III criteria but considerably
lower than the estimate of 37% derived from using the
IDF criteria.9 For comparison, estimates of the
age-standardised prevalence of metabolic syndrome in
the USA are 23%.10
In a multivariable analysis, the risk of metabolic syndrome increased steadily with age: participants aged 60–
64 were 18 times more likely to suffer from metabolic
syndrome than those who were in the 18–30 age group.
The frequency of metabolic syndrome was 39% lower
among participants with the highest level of educational
attainment than in the group with the least amount of
education. Exercise of at least 3000 MET-min/week
lowered the risk of metabolic syndrome by 40% compared with persons in the lowest exercise group. Neither
diet nor smoking had any impact on the occurrence of
metabolic syndrome in this survey. This could be due to
the fact that only basic information was collected on diet
and because smoking prevalence is relatively low in
Qatar. This analysis, however, suggests that among the
various lifestyle factors that might alter the prevalence of
metabolic syndrome in Qatar, exercise is the most
important and deserves emphasis in any disease prevention programme.
Of interest, about 70% of participants in the sample
survey were unaware of pre-existing diabetes or hypertension. After evaluation, 16.5% in this group were eventually diagnosed with metabolic syndrome.
The availability of speciﬁc waist circumference cut-off
points for Qataris will also allow a better identiﬁcation of
the metabolic syndrome at the individual level in this
Al-Thani MH, et al. BMJ Open 2016;6:e009514. doi:10.1136/bmjopen-2015-009514

population. Using lower cut-off points for Europeans,
which are recommended in the absence of ethnicity speciﬁc data, would markedly increase the number of individuals classiﬁed at risk of Mets.
The strength of this study is that the data came from a
carefully selected random population sample and data
collection followed well-deﬁned WHO criteria. As in
other surveys, there was a different response rate for each
step, especially for the collection of biological material.
Fifty-ﬁve per cent of participants in the Qatar National
STEPwise Survey provided a blood sample, which is still a
fair response rate. Many individuals who live in this
region refuse to provide blood samples for a variety of
cultural reasons in survey situations such as this one, but
we have no reason to believe that the blood sugar values
of study participants who provided blood samples are different from the values of those who did not. However,
this might introduce an unknown bias into the estimate
of the prevalence of metabolic syndrome. We also recognised that treating missing data as a category in the
regression models, as any other method to handle
missing data, such as dropping subjects or imputation,
could again have introduced some bias.
Another study limitation pertains to the accuracy of
self-reported dietary information. This information is an
estimate, which may not be a true measure of past or
present food consumption. This could lead to inappropriate conclusions that the diet has no signiﬁcant impact
on prevention of metabolic syndrome. Finally, as for any
population survey, the assumption was made that the
sample of individuals interviewed is representative of the
whole population. Our careful sampling framework
should guarantee this assumption.
In summary, using new ethnic-speciﬁc cut-off points
(≥102 for men and ≥94 cm for women) derived from
the ROC curve analysis of abdominal waist circumference, the prevalence of metabolic syndrome in adult
Qataris is 28%. We believe the new cut-off points for
waist measurement from this country could be suitable
for estimating the prevalence of metabolic syndrome in
similar populations from other Middle East countries
where country-speciﬁc data for waist measurements are
unavailable.
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